FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to experimental pharmacology, and concerns correction of normal microflora composition in experiment. It is ensured by introduction to laboratory animals of 6-piperidinomethyl-2,3-dihydroquercetin- C21H23NO7.
EFFECT: method provides extended range of chemical agents that provide normalisation of colon microflora composition.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STRAIN OF ENTEROCOCCUS STREPTOCOCCUS FAECIUM USED FOR PREPARING BACTERITIC PREPARATIONS | 0 |
|
SU1497211A1 |
| METHOD OF TREATMENT OF DYSBACTERIOSIS OF INTESTINE | 0 |
|
SU1286212A1 |
| BIOLOGICALLY ACTIVE PREPARATION FOR CORRECTION OF DISTURBANCE IN DIGESTIVE TRACT MICROFLORA AND ENHANCEMENT OF GENERAL RESISTANCE OF BODY | 2003 |
|
RU2246958C1 |
| METHOD FOR SIMULATING INTESTINAL DYSBACTERIOSIS IN LABORATORY ANIMALS | 2011 |
|
RU2477894C1 |
| METHOD TO ASSESS EFFECT OF EXOGENOUS FACTORS AT INTESTINAL MICROFLORA IN CASE OF ITS DYSBIOTIC DISTURBANCES | 2012 |
|
RU2483113C1 |
| AGENT FOR REDUCTION OF INTESTINAL MICROBIOCENOSIS IN CASE OF DYSBIOSIS | 2015 |
|
RU2593584C1 |
| METHOD OF TREATING INTESTINAL DYSBACTERIOSIS | 2015 |
|
RU2602696C1 |
| METHOD OF TREATING PATIENTS WITH INTESTINAL DYSBACTERIOSIS | 2009 |
|
RU2400235C1 |
| METHOD FOR PREVENTION OF DEVELOPING BACTERIAL INTESTINAL INFECTION | 2012 |
|
RU2526806C2 |
| AGENT FOR THE PREVENTION AND TREATMENT OF ULCERATE COLITIS | 2017 |
|
RU2649119C1 |
